IZI. I. Zhirkov

I. I. Zhirkov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


I. I. Zhirkov has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • HEART FAILURE CLINICAL MANIFESTATIONS FEATURES IN MYOCARDIAL INFARCTION, COMPLICATED BY THROMBOEMBOLISM, IN MALES UNDER 60 YEARS OLD

    by Gordienko A.V., Shikhverdiev N.N., Epifanov S.YU., Yakovlev A.V., Zhirkov I.I., Tkachev E.V., Asyamov K.V., Bobakov N.V.

    Thromboembolism and heart failure are among the most frequent causes of death in myocardial infarction. Purpose of the study. To study the peculiarities of clinical manifestations of heart failure in myocardial infarction complicated by thromboembolism development in men younger than 60 years old to improve prevention and outcomes. Material and Methods. Men 19-60 years old with myocardial infarction type I were included in the study. Patients were divided into age-matched groups. The study group consisted of 29 patients with thromboembolism, control group - without thromboembolism - 658 patients. A comparative analysis of objective manifestations of heart failure in the selected groups was performed. Results. In the study group in comparison with the control group the predominance of the frequency of variants of clinical course of myocardial infarction mixed with heart failure was revealed (in the study group - 32,1%; in the control group - 17,3%, respectively; p˂0,0001), its complicated course (100% and 56,0%, respectively; p˂0,0001) with multiple complications (100% and 44.8%; p˂0.0001), heart failure at the end of the eighth week of illness (77.7% and 42.8%; p=0.03), frequency of observation of cyanosis (89.3%; 67.9%; p=0.02), dyspnea (82.1% and 45.4%; p=0.0001), pulmonary rales (64.3% and 40.5%; p=0.01), arrhythmias (57.1% and 22.5%; p˂0.0001) and liver enlargement (53.6% and 15.8%; p˂0.0001), a measure of patients' quality of life related to heart failure (79.83±17.92 and 60.31±20.46; p˂0.0001). Reliable dynamics of objective signs of heart failure in the studied group was obtained only for dyspnea (p˂0.0001). Conclusions. The patients of the studied group have predominant manifestations of heart failure both in the first hours and at the end of the third week of the disease. Complicated course of myocardial infarction with a variety of their combinations dominates in this group. Dyspnea is the most sensitive symptom to changes in the condition of patients in the study group. In this group there is a high prevalence of heart failure after the eighth week of myocardial infarction.

  • Open Access

    Prognostic mathematical models of the development of chronic non-viral liver diseases

    by I. I. Zhirkov, A. V. Gordienko, B. A. Chumak, I. M. Pavlovich, V. V. Yakovlev, D. Yu. Serdukov

    Chronic non-viral liver diseases are one of the most pressing problems of modern internal medicine. Over the past two decades, there has been a steady increase in diseases of this group due to the widespread prevalence of major risk factors, such as obesity, diabetes mellitus, physical inactivity, alcohol abuse, irrational use of medications, etc. Since most of the patients represent the most able-bodied and active part of the population, this circumstance inevitably leads to significant financial, economic and humanitarian losses, which gives the problem acute social significance. The purpose of the study. To develop mathematical prognostic models of the development of the most common chronic non-viral liver pathology using the most important predictors of these diseases. Material and methods. The contingent included in the study consisted of 412 young and middle-aged men, 138 of them with non-alcoholic fatty liver disease, 50 with alcoholic liver disease, 157 with alcoholic-metabolic fatty liver disease and 67 people without pathology. The subjects were measured anthropometric indicators (height, body weight, calculation of body mass index, waist circumference), determination of the type of alcohol consumption according to the AUDIT questionnaire, the level of physical activity according to the IPAQ questionnaire. In the biochemical study of blood serum, the parameters of alanine and aspartate aminotransferase, total and direct bilirubin, alkaline phosphatase, gamma-glutamyltranspeptidase, glucose, insulin, and lipid spectrum were determined. The study of the qualitative and quantitative composition of the intestinal microbiome was carried out by sowing feces on nutrient media, followed by the determination of the species of microorganisms and the assessment of their quantitative content using microscopy. Ultrasound examination of the hepatobiliary zone included measuring the main sizes of the right and left lobes of the liver, as well as identifying the main signs of diffuse liver damage. To assess steatosis and liver fibrosis, a FibroScan 530 device was used with the functions of evaluating the parameter of controlled attenuation of ultrasound and transient elastography by controlled vibration. Statistical processing and analysis of the results obtained were performed using the StatTech 2.8.8 program. Results. Mathematical prognostic models have been developed to determine the probability of developing non-alcoholic fatty liver disease, alcoholic fatty liver disease and alcoholic-metabolic fatty liver disease. All the regression models obtained were statistically significant with sensitivity and specificity of more than 90%. AUROC diagnostic accuracy values exceeded 0.9 units, which characterizes the quality of diagnostic models as excellent. Conclusions. The use of mathematical prognostic models using publicly available data from objective and laboratory research methods allows optimizing the diagnosis of chronic non-viral liver diseases.


  • Open Access

    Diagnosis of liver fibrosis: an emphasis on elastography

    by I. I. Zhirkov, A. V. Gordienko, I. M. Pavlovich, B. A. Chumak, V. V. Yakovlev

    In the strategy of managing patients with chronic diffuse liver diseases, the priority areas are the determination of the diagnosis with the determination of the main risk factors, the activity of the process (steatosis, steatohepatitis), as well as the degree of fibrous transformation. The rate of progression of liver fibrosis is a decisive factor that will determine the prognosis, treatment tactics and the likelihood of severe complications. The “gold standard” for diagnosing chronic liver pathology is a puncture liver biopsy with morphological examination of the liver tissue. At the same time, potential complications, contraindications to the procedure, low patient compliance, as well as errors in the interpretation of the results obtained due to various reasons are significant limitations of this diagnostic method. These shortcomings were the reason for the search for reliable non-invasive methods for diagnosing liver fibrosis both during the initial examination and during subsequent monitoring in dynamics. Modern methods of liver elastography are widely used for non-invasive assessment of fibrosis, demonstrating good diagnostic capabilities and significantly reducing the need for liver biopsy. Various elastography methods, which have their own advantages and disadvantages, effectively complement each other, which is successfully used in clinical practice in the diagnosis of fibrous transformation. The combined use of elastographic methods and commercial predictive diagnostic panels will increase the diagnostic accuracy in the determination of liver fibrosis.


  • Open Access

    Possibilities of transient and two-dimensional shear wave elastography in the diagnosis of fibrosis in chronic diffuse liver diseases of non-viral etiology

    by I. I. Zhirkov, A. V. Gordienko, I. M. Pavlovich, V. V. Yakovlev, D. Yu. Serdyukov, Д. Ю. Сердюков

    The aim of the research: to study the possibilities of transient and two-dimensional shear wave elastography in the diagnosis of fibrosis in chronic diffuse liver diseases of non-viral etiologyMaterials and methods: the study included 415 male patients aged 19 to 54 years (average age 40.4 ± 7.8 years), including 156 with non-alcoholic fatty liver disease, 66 with alcoholic liver disease, 122 with fatty disease liver alcohol-metabolic etiology, 68 people without liver disease. The examination plan included the measurement of anthropometric indicators, a biochemical study of blood serum, an ultrasound study of the hepatobiliary zone, a morphological study of liver tissue, transient and two-dimensional shear wave elastography.Results: according to the results of transient and two-dimensional shear wave elastography, the degree of fibrotic changes with combined alcohol-metabolic liver disease is higher than with isolated exposure to an alcoholic or metabolic factor; the highest diagnostic significance in elastographic research methods was noted in the third and fourth stages of fibrosis, in the second stage, the quality of the diagnostic model in transient elastography was higher than in two-dimensional shear wave.


  • Open Access

    Noninvasive methods of diagnosis of steatosis in non-alcoholic fatty liver disease

    by I. I. Zhirkov, A. V. Gordienko, I. M. Pavlovich, V. Yu. Golofeevsky, O. V. Makoveeva, В. Ю. Голофеевский

    The aimof the research: to study the diagnostic capabilities of non-invasive methods for the diagnosis of hepatic steatosis in patients with NAFLD.Materials and methods: the study included 240 male patients aged 21 to 54 years (mean age 41,1 ± 8,1 years), 172 of them with non-alcoholic fatty liver disease, 68 without this pathology. All performed measurement of anthropometric parameters, biochemical study of blood serum, ultrasound examination of the hepatobiliary zone, calculation of diagnostic indices of steatosis (FLI and HSI), non-invasive determination of the degree of steatosis on the device FibroScan with function CAP.Results: the CAP values of the FibroScan apparatus, as well as indicators of predictive steatosis indices signifi cantly (p<0,05) diff ered in the study groups; the quality of diagnostic models, estimated by the AUROC index, in the steatosis indices FLI and HIS was recognized as excellent, in the CAP values of the FibroScan apparatus as very good.